×
Home Current Archive Editorial board
News Contact
Review paper

Lung cancer screening in the healthcare system of Bosnia and Herzegovina

By
Larisa Gavran Orcid logo ,
Larisa Gavran
Contact Larisa Gavran

Department of Family Medicine, School of Medicine, University of Zenica , Zenica , Bosnia and Herzegovina

Family Medicine Teaching Centre, Primary Health Care , Zenica , Bosnia and Herzegovina

Gina Fatahi ,
Gina Fatahi

Comprehensive Cancer Center, Ohio State University , Ohio , Colombia

Maja Račić
Maja Račić

Comprehensive Cancer Center, Ohio State University , Ohio , Colombia

Abstract

Lung cancer incidence in Bosnia and Hercegovina is high. The implementation of evidence-based lung cancer screening based on low-dose computed tomography (LDCT) may detect lung cancer early and decrease mortality specific to lung cancer. However, LDCT receipt may be unsatisfactory in Europe due to a low distribution of scanners and radiologists or poor access to care. In this paper, we propose a framework for the implementation of lung cancer screening in primary healthcare of Bosnia and Herzegovina based on the United States Preventative Services Task Force recommendation from 2021 and the American College of Radiology Lung CT Screening Reporting & Data System from 2022. 

References

1
Moyer V. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014:330–8.
2
American College of Radiology. Lung CT Screening Reporting and Data System (Lung-RADS): Assessment Categories 2022.
3
Doubeni C, Wilkinson J, Korsen N, Midthun D. Lung cancer screening guidelines implementation in primary care: A Call to Action. Ann Fam Med 2020:196–201.
4
Brenner A, Malo T, Margolis M, Lafata E, James J, Vu S, et al. Evaluating shared decision making for lung cancer screening. JAMA Intern Med 2018:1311–6.
5
Haas J, Sprague B, Klabunde C, Tosteson A, Chen J, Bitton A, et al. PROSPR (Population-based Research Optimizing Screening through Personalized Regimens) Consortium. Provider attitudes and screening practices following changes in breast and cervical cancer screening guidelines. J Gen Intern Med 2016:52–9.
6
Hamann H, Hoeve V, Carter-Harris E, Studts L, Ostroff J, J. Multilevel opportunities to address lung cancer stigma across the cancer control continuum. J Thorac Oncol 2018:1062–75.
7
Lei F, Lee E. Barriers to lung cancer screening with low-dose computed Tomography. Oncol Nurs Forum 2019:60–71.
8
Balata H, Evison M, Sharman A, Crosbie P, Booton R. CT screening for lung cancer: Are we ready to implement in Europe? Lung Cancer 2019:25–33.
9
Oudkerk M, Devaraj A, Vliegenthart R, Henzler T, Prosch H, Heussel C, et al. European position statement on lung cancer screening. Lancet Oncol 2017:754-e766.
10
Us Preventive S, Task Force ;, Krist A, Davidson K, Mangione C, Barry M, et al. Screening for lung cancer: US Preventive Services Task Force recommendation statement. JAMA 2021:962–70.
11
Jeon J, Holford T, Levy D, Feuer E, Cao P, Tam J, et al. Smoking and lung cancer mortality in the United States from 2015 to 2065: a comparative modeling approach. Ann Intern Med 2018:684–93.
12
Pastorino U, Silva M, Sestini S, Sabia F, Boeri M, Cantarutti A, et al. Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy. Ann Oncol 2019:1162–9.
13
De Koning H, Van Der Aalst C, De Jong P, Scholten E, Nackaerts K, Heuvelmans M, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med 2020:503–13.
14
Aberle D, Berg C, Black W, Church T, Fagerstrom R, Galen B, et al. The National Lung Screening Trial: overview and study design. Radiology 2011:243–53.
15
Ebell M, Bentivegna M, Hulme C. Cancer-specific mortality, all-cause mortality, and overdiagnosis in lung cancer screening trials: a meta-analysis. Ann Fam Med 2020:545–52.
16
Javna zdravstvena ustanova Institut za javno zdravstvo Republike Srpske (Public Health Institue of the Republic of Srpska) 13AD.
17
Zavod za javno zdravstvo Federacije Bosne i Hercegovine (Institute for Public Health FB&H) 14AD.
18
Lj M, Vukojević B, Pepić A, Preradović D, Gligorić D. Tobacco consumption in Bosnia and Herzegovina 2019.
19
Wipfli H, Samet J. One hundred years in the making: the global tobacco epidemic. Annu Rev Public Health 2016:149–66.
20
Siegel R, Miller K, Fuchs H, Jemal A. Cancer statistics, 2022. CA Cancer J Clin 2022:7–33.

Citation

Authors retain copyright. This work is licensed under a Creative Commons Attribution 4.0 International License. Creative Commons License

 

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.